Lili Ren, Tatsuo Matsuda, Boya Deng, Kazuma Kiyotani, Taigo Kato, Jae-Hyun Park, Tanguy Y. Seiwert, Everett E. Vokes, Nishant Agrawal, and Yusuke Nakamura
Oncotarget. 2018 January 9;9(3):3805-3814
PMID: 29423084
Apollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, Deedra Nicolet, Stefano Volinia, Bayard L. Powell, Jonathan E. Kolitz, Geoffrey L. Uy, Richard M. Stone, Steven M. Kornblau, Michael Andreeff, Carlo M. Croce, Clara D. Bloomfield, and Ramiro Garzon
Oncotarget. 2018 January 12;9(4):4354-4365
PMID: 29435107
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
Renumathy Dhanasekaran, Meital Gabay-Ryan, Virginie Baylot, Ian Lai, Adriane Mosley, Xinqiang Huang, Sonya Zabludoff, Jian Li, Vivek Kaimal, Priya Karmali, and Dean W. Felsher
Oncotarget. 2018 January 19;9(5):5517-5528
PMID: 29464015
Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor
Kelley E. McQueeney, Joseph M. Salamoun, James C. Burnett, Nektarios Barabutis, Paula Pekic, Sophie L. Lewandowski, Danielle C. Llaneza, Robert Cornelison, Yunpeng Bai, Zhong-Yin Zhang, John D. Catravas, Charles N. Landen, Peter Wipf, John S. Lazo, and Elizabeth R. Sharlow
Oncotarget. 2018 February 5;9(9):8223-8240
PMID: 29492190
Céléna Dubuc, Martin Savard, Veronica Bovenzi, Andrée Lessard, Audrey Fortier, Jérôme Côté, Witold Neugebauer, Flavio Rizzolio, Sameh Geha, Antonio Giordano, Sylvain Chemtob, and Fernand Gobeil
Oncotarget. 2018 January 5;9(11):9885-906
PMID: 29515778
Taigo Kato, Tatsuo Matsuda, Yuji Ikeda, Jae-Hyun Park, Matthias Leisegang, Sachiko Yoshimura, Tetsuro Hikichi, Makiko Harada, Makda Zewde, Sho Sato, Kosei Hasegawa, Kazuma Kiyotani, and Yusuke Nakamura
Oncotarget. 2018 Feb 5;9(13):11009
PMID: 29541393
Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention
Juana Martín-López, Pierluigi Gasparini, Kevin Coombes, Carlo M. Croce, Gregory P. Boivin, and Richard Fishel
Oncotarget. 2018 Feb 27;9(16):12554-61
PMID: 29560090
Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation
Sara Pagotto, Angelo Veronese, Alessandra Soranno, Paola Lanuti, Mirco Di Marco, Marco Vincenzo Russo, Alice Ramassone, Marco Marchisio, Pasquale Simeone, Paolo E. Guanciali Franchi, Giandomenico Palka, Renato Mariani Costantini, Carlo M. Croce, and Rosa Visone
Oncotarget. 2018 Feb 27;9(16):13036-47
PMID: 29560129
Sara Pagotto, Maria Peiris-Pagès, Gloria Bonuccelli, Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2018 March 27;9(17):13254-75
PMID: 29568355
Dynamic changes during the treatment of pancreatic cancer
Robert A. Wolff, Andrea Wang-Gillam, Hector Alvarez, Hervé Tiriac, Dannielle Engle, Shurong Hou, Abigail F. Groff, Anthony San Lucas, Vincent Bernard, Kelvin Allenson, Jonathan Castillo, Dong Kim, Feven Mulu, Jonathan Huang, Bret Stephens, Ignacio I. Wistuba, Matthew Katz, Gauri Varadhachary, YoungKyu Park, James Hicks, Arul Chinnaiyan, Louis Scampavia, Timothy Spicer, Chiara Gerhardinger, Anirban Maitra, David Tuveson, John Rinn, Gregory Lizee, Cassian Yee, and Arnold J. Levine
Oncotarget. 2018 March 13;9(19):14764-90
PMID: 29599906
Farzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, Angelo Sangiovanni, Paola Guerriero, Giuseppina De Petro, Cristian Bassi, Laura Lupini, Arash Sattari, Douglas Cheung, Dario Veneziano, Giovanni Nigita, Ram C. Shankaraiah, Nazario Portolani, Paolo Carcoforo, Francesca Fornari, Luigi Bolondi, Antonio Frassoldati, Silvia Sabbioni, Massimo Colombo, Carlo M. Croce, and Massimo Negrini
Oncotarget. 2018 March 16;9(20):15350-64
PMID: 29632649
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Cesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, Kazuma Kiyotani, Alfred Rademaker, Ami N. Shah, Leeaht Gross, Luis Z. Blanco, Sarika Jain, Lisa Flaum, Claudia Tellez, Regina Stein, Regina Uthe, William J. Gradishar, Massimo Cristofanilli, Yusuke Nakamura, and Francis J. Giles
Oncotarget. 2018 April 10;9(27):18985-96
PMID: 29721177
Davide Valentini, Martin Rao, Qingda Meng, Anna von Landenberg, Jiri Bartek Jr, Georges Sinclair, Georgia Paraschoudi, Elke Jäger, Inti Harvey-Peredo, Ernest Dodoo, and Markus Maeurer
Oncotarget. 2018 April 13;9(28):19469-80
PMID: 29731959
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma
Giorgio Malpeli, Stefano Barbi, Corinna Greco, Simonetta Zupo, Anna Bertolaso, Maria Teresa Scupoli, Mauro Krampera, Paul Takam Kamga, Carlo Maria Croce, Aldo Scarpa, and Alberto Zamò
Oncotarget. 2018 April 13;9(28):19961-79
PMID: 29731996
Pierpaolo Correale, Cirino Botta, Nicoletta Staropoli, Valerio Nardone, Pierpaolo Pastina, Cristina Ulivieri, Claudia Gandolfo, Tatiana Cosima Baldari, Stefano Lazzi, Domenico Ciliberto, Rocco Giannicola, Antonella Fioravanti, Antonio Giordano, Silvia Zappavigna, Michele Caraglia, Pierfrancesco Tassone, Luigi Pirtoli, Maria Grazia Cusi, and Pierosandro Tagliaferri
Oncotarget. 2018 April 17;9(29):20539-54
PMID: 29755670
Aspirin induces autophagy via inhibition of the acetyltransferase EP300
Francesca Castoldi, Federico Pietrocola, Maria Chiara Maiuri, and Guido Kroemer
Oncotarget. 2018 May 15;9(37):24574-75
PMID: 29872488
David K. Edwards V, David Tyler Sweeney, Hibery Ho, Christopher A. Eide, Angela Rofelty, Anupriya Agarwal, Selina Qiuying Liu, Alexey V. Danilov, Patrice Lee, David Chantry, Shannon K. McWeeney, Brian J. Druker, Jeffrey W. Tyner, Stephen E. Spurgeon, and Marc M. Loriaux
Oncotarget. 2018 May 15;9(37):24576-89
PMID: 29872489
Marisa Sanchez, Zebin Xia, Elizabeth Rico-Bautista, Xihua Cao, Michael Cuddy, David J. Castro, Ricardo G. Correa, Liqun Chen, Jinghua Yu, Andrey Bobkov, Vivian Ruvolo, Michael Andreeff, Robert G. Oshima, Shu-Ichi Matsuzawa, John C. Reed, Xiao-Kun Zhang, Donna Hansel, Dieter A. Wolf, and Marcia I. Dawson
Oncotarget. 2018 May 18;9(38):25057-74
PMID: 29861853
Active lifestyles in older adults: an integrated predictive model of physical activity and exercise
Federica Galli, Andrea Chirico, Luca Mallia, Laura Girelli, Michelino De Laurentiis, Fabio Lucidi, Antonio Giordano, and Gerardo Botti
Oncotarget. 2018 May 22;9(39):25402-13
PMID: 29875997
Activated matriptase as a target to treat breast cancer with a drug conjugate
Gulam M. Rather, Siang-Yo Lin, Hongxia Lin, Whitney Banach-Petrosky, Kim M. Hirshfield, Chen-Yong Lin, Michael D. Johnson, Zoltan Szekely, and Joseph R. Bertino
Oncotarget. 2018 May 25;9(40):25983-92
PMID: 29899836
Tengjiao Cui, and Andrew V. Schally
Oncotarget. 2018 June 19;9(47):28745-56
PMID: 29983893
Cory Pettit, Amy Webb, Steve Walston, Moumita Chatterjee, Wei Chen, Wendy Frankel, Carlo Croce, and Terence M. Williams
Oncotarget. 2018 June 22;9(48):28951-64
PMID: 29988972
Giorgio Malpeli, Stefano Barbi, Gabriele Tosadori, Corinna Greco, Simonetta Zupo, Serena Pedron, Matteo Brunelli, Anna Bertolaso, Maria Teresa Scupoli, Mauro Krampera, Paul Takam Kamga, Carlo Maria Croce, George Adrian Calin, Aldo Scarpa, and Alberto Zamò
Oncotarget. 2018 July 3;9(51):29753-71
PMID: 30038718
Lígia Catarina Gomes-da-Silva, Liwei Zhao, Luis G. Arnaut, Guido Kroemer, and Oliver Kepp
Oncotarget. 2018 July 27;9(58):31169-70
PMID: 30131844
Theodore Vougiouklakis, Vassiliki Saloura, Jae-Hyun Park, Naofumi Takamatsu, Takashi Miyamoto, Yusuke Nakamura, and Yo Matsuo
Oncotarget. 2018 August 7;9(61):31820-31
PMID: 30159125
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
Kelly G. Bryant, Young Chan Chae, Rogelio L. Martinez, John C. Gordon, Khaled M. Elokely, Andrew V. Kossenkov, Steven Grant, Wayne E. Childers, Magid Abou-Gharbia and Dario C. Altieri
Oncotarget. 2017 Dec 22;8(68):112184-98
PMID: 29348817
Lysosome-targeting agents in cancer therapy
Guido Kroemer and Lorenzo Galluzzi
Oncotarget. 2017 Dec 22;8(68):112168-69
PMID: 29348815
Alessia Fidoamore, Loredana Cristiano, Chiara Laezza, Renato Galzio, Elisabetta Benedetti, Benedetta Cinque, Andrea Antonosante, Michele d’Angelo, Vanessa Castelli, Maria Grazia Cifone, Rodolfo Ippoliti, Antonio Giordano and Annamaria Cimini
Oncotarget. 2017 Dec 12;8(65):108430-50
PMID: 29312541
Ourania N. Kostopoulou, Vanessa Wilhelmi, Sina Raiss, Sharan Ananthaseshan, Mikael S. Lindström, Jiri Bartek and Cecilia Söderberg-Naucler
Oncotarget. 2017 Nov 14;8(57):96536-52
PMID: 29228551
Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy
Valentina Sica, José Manuel Bravo-San Pedro, Guo Chen, Guillermo Mariño, Sylvie Lachkar, Valentina Izzo, Maria Chiara Maiuri, Mireia Niso-Santano and Guido Kroemer
Oncotarget. 2017 Oct 27;8(52):89527–38
PMID: 29207686
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers
Mohamed E. Salem, Benjamin A. Weinberg, Joanne Xiu, Wafik S. El-Deiry, Jimmy J. Hwang, Zoran Gatalica, Philip A. Philip, Anthony F. Shields, Heinz-Josef Lenz, and John L. Marshall
Oncotarget. 2017 Oct 10;8(49):86356-68
PMID: 29156800
Louise Y. Fong, Ruiyan Jing, Karl J. Smalley, Cristian Taccioli, Johannes Fahrmann, Dinesh K. Barupal, Hansjuerg Alder, John L. Farber, Oliver Fiehn, and Carlo M. Croce
Oncotarget. 2017 Oct 10;8(47):81910-25
PMID: 29137232
Avital Lev, Amriti R. Lulla, Jessica Wagner, Marie D. Ralff, Joshua B. Kiehl, Yan Zhou, Cyril H. Benes, Varun V. Prabhu, Wolfgang Oster, Igor Astsaturov, David T. Dicker, and Wafik S. El-Deiry
Oncotarget. 2017 Oct 10;8(47):81776-93
PMID: 29137221
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
Timothy G. Pestell, Xuanmao Jiao, Mukesh Kumar, Amy R. Peck, Marco Prisco, Shengqiong Deng, Zhiping Li, Adam Ertel, Mathew C. Casimiro, Xiaoming Ju, Agnese Di Rocco, Gabriele Di Sante, Sanjay Katiyar, Alison Shupp, Michael P. Lisanti, Pooja Jain, Kongming Wu, Hallgeir Rui, Douglas C. Hooper, Zuoren Yu, Aaron R. Goldman, David W. Speicher, Lisa Laury-Kleintop, and Richard G. Pestell
Oncotarget. 2017 Oct 10;8(47):81754-75
PMID: 29137220
Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
Zhenjiang Liu, Martin Rao, Thomas Poiret, Silvia Nava, Qingda Meng, Anna von Landenberg, Jiri Bartek Jr., Shanshan Xie, Georges Sinclair, Inti Peredo, Ernest Dodoo, and Markus Maeurer
Oncotarget. 2017 Oct 6;8(46):80208-22
PMID: 29113296
Bela Ozsvari, Federica Sotgia, Katie Simmons, Rachel Trowbridge, Richard Foster, and Michael P. Lisanti
Oncotarget. 2017 Oct 3;8(45):78340-50
PMID: 29108233
Candace J. Poole, Wenli Zheng, Atul Lodh, Aleksey Yevtodiyenko, Daniel Liefwalker, Honglin Li, Dean W. Felsher, and Jan van Riggelen
Oncotarget. 2017 Sept 29;8(44):76898-920
PMID: 29100357
Pierpaolo Pastina, Valerio Nardone, Cirino Botta, Stefania Croci, Paolo Tini, Giuseppe Battaglia, Veronica Ricci, Maria Grazia Cusi, Claudia Gandolfo, Gabriella Misso, Silvia Zappavigna, Michele Caraglia, Antonio Giordano, Donatella Aldinucci, Pierfrancesco Tassone, Pierosandro Tagliaferri, Luigi Pirtoli, and Pierpaolo Correale
Oncotarget. 2017 Sept 29;8(44):75904-13
PMID: 29100279
Federica Sotgia, Marco Fiorillo, and Michael P. Lisanti
Oncotarget. 2017 Sept 15;8(40):68730-45
PMID: 28978152
Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2017 Sept 15;8(40):68095-107
PMID: 28978099
Bela Ozsvari, Marco Fiorillo, Gloria Bonuccelli, Anna Rita Cappello, Luca Frattaruolo, Federica Sotgia, Rachel Trowbridge, Richard Foster, and Michael P. Lisanti
Oncotarget. 2017 Sept 15;8(40):67457-72
PMID: 28978045
Ernestina Marianna De Francesco, Gloria Bonuccelli, Marcello Maggiolini, Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2017 Sept 15;8(40):67269-86
PMID: 28978032
Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2017 Sept 15;8(40):67117-28
PMID: 28978020
Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2017 Sept 15;8(40):66925-39
PMID: 28978006
Expression of hypothalamic neurohormones and their receptors in the human eye
Sander R. Dubovy, Maria P. Fernandez, Jose J. Echegaray, Norman L. Block, Noriyuki Unoki, Roberto Perez, Irving Vidaurre, Richard K. Lee, Mehrdad Nadji, and Andrew V. Schally
Oncotarget. 2017 Sept 15;8(40):66796-814
PMID: 28977997
Niklas K. Finnberg, Prashanth Gokare, Avital Lev, Sergei I. Grivennikov, Alexander W. MacFarlane IV, Kerry S. Campbell, Ryan M. Winters, Karen Kaputa, Jeffrey M. Farma, Abbas El-Sayed Abbas, Luigi Grasso, Nicholas C. Nicolaides, and Wafik S. El-Deiry
Oncotarget. 2017 Sept 15;8(40):66747-57
PMID: 28977993
Yingyu Ma, Wei Luo, Brittany L. Bunch, Rachel N. Pratt, Donald L. Trump, and Candace S. Johnson
Oncotarget. 2017 Sept 1;8(36):60080-93
PMID: 28947955
Ernestina Marianna De Francesco, Marcello Maggiolini, Herbert B. Tanowitz, Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2017 Aug 22;8(34):56126-42
PMID: 28915578
Yoshihiro Ito, Peter K. Vogt, and Jonathan R. Hart
Oncotarget. 2017 Aug 22;8(34):55863-76
PMID: 28915558
Alice Agliano, Geetha Balarajah, Daniela M. Ciobota, Jasmin Sidhu, Paul A. Clarke, Chris Jones, Paul Workman, Martin O. Leach, and Nada M.S. Al-Saffar
Oncotarget. 2017 July 18;8(29):47969-83
PMID: 28624789
The tuberous sclerosis complex gets fatter
Prashanth Gokare, and Wafik S. El-Deiry
Oncotarget. 2017 June 27;8(26):41780-81
PMID: 28611315
Safoora Deihimi, Avital Lev, Michael Slifker, Elena Shagisultanova, Qifang Xu, Kyungsuk Jung, Namrata Vijayvergia, Eric A. Ross, Joanne Xiu, Jeffrey Swensen, Zoran Gatalica, Mark Andrake, Roland L. Dunbrack, and Wafik S. El-Deiry
Oncotarget. 2017 June 20;8(25):39945-62
PMID: 28591715
Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma
Chiaki Tsuge Ishida, Chang Shu, Marc-Eric Halatsch, Mike-Andrew Westhoff, Dario C. Altieri, Georg Karpel-Massler, and Markus David Siegelin
Oncotarget. 2017 June 6;8(23):37140-53
PMID: 28415755
Andrea Chirico, Fabio Lucidi, Thomas Merluzzi, Fabio Alivernini, Michelino De Laurentiis, Gerardo Botti, and Antonio Giordano
Oncotarget. 2017 May 30;8(22):36800-11
PMID: 28404938
Ultraconserved long non-coding RNA uc.63 in breast cancer
Alberto Marini, Anna Maria Lena, Emanuele Panatta, Cristina Ivan, Leng Han, Han Liang, Margherita Annicchiarico-Petruzzelli, Nicola Di Daniele, George A. Calin, Eleonora Candi, and Gerry Melino
Oncotarget. 2017 May 30;8(22):35669-80
PMID: 27447964
Michal Mego, Hui Gao, Evan N. Cohen, Simone Anfossi, Antonio Giordano, Sanda Tin, Tamer M. Fouad, Ugo De Giorgi, Mario Giuliano, Wendy A. Woodward, Ricardo H. Alvarez, Vicente Valero, Naoto T. Ueno, Gabriel N. Hortobagyi, Massimo Cristofanilli, and James M. Reuben
Oncotarget. 2017 May 30;8(22):35656-68
PMID: 27374101
Genetic landscape of extreme responders with anaplastic oligodendroglioma
Matthias Holdhoff, Gregory J. Cairncross, Thomas M. Kollmeyer, Ming Zhang, Peixin Zhang, Minesh P. Mehta, Maria Werner-Wasik, Luis Souhami, Jean-Paul Bahary, Young Kwok, Alan C. Hartford, Arnab Chakravarti, Srinivasan Yegnasubramanian, Bert Vogelstein, Nickolas Papadopoulos, Kenneth Kinzler, Robert B. Jenkins, and Chetan Bettegowda
Oncotarget. 2017 May 30;8(22):35523-31
PMID: 28388591
Giovanna Carrà, Cristina Panuzzo, Davide Torti, Guido Parvis, Sabrina Crivellaro, Ubaldo Familiari, Marco Volante, Deborah Morena, Marcello Francesco Lingua, Mara Brancaccio, Angelo Guerrasio, Pier Paolo Pandolfi, Giuseppe Saglio, Riccardo Taulli, and Alessandro Morotti
Oncotarget. 2017 May 30;8(22):35508-22
PMID: 28418900
Nilofer S. Azad, Anthony el-Khoueiry, Jun Yin, Ann L. Oberg, Patrick Flynn, Douglas Adkins, Anup Sharma, Daniel J. Weisenberger, Thomas Brown, Prakriti Medvari, Peter A. Jones, Hariharan Easwaran, Ihab Kamel, Nathan Bahary, George Kim, Joel Picus, Henry C. Pitot, Charles Erlichman, Ross Donehower, Hui Shen, Peter W. Laird, Richard Piekarz, Stephen Baylin, and Nita Ahuja
Oncotarget. 2017 May 23;8(21):35326-38
PMID: 28186961
ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer
Jian-Kang Zhou, Yu-Zhu Zheng, Xue-Sha Liu, Qiheng Gou, Rui Ma, Cheng-Lin Guo, Carlo M. Croce, Lunxu Liu, and Yong Peng
Oncotarget. 2017 May 16;8(20):32864-72
PMID: 28427197
Emmanuel K. Teye, Abigail Sido, Ping Xin, Niklas K. Finnberg, Prashanth Gokare, Yuka I. Kawasawa, Anna C. Salzberg, Sara Shimko, Michael Bayerl, W. Christopher Ehmann, David F. Claxton, Witold B. Rybka, Joseph J. Drabick, Hong-Gang Wang, Thomas Abraham, Wafik S. El-Deiry, Robert A. Brodsky, Raymond J. Hohl, and Jeffrey J. Pu
Oncotarget. 2017 May 2;8(18):29887-905
PMID: 28187452
Rosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, Anna De Blasio, Christian Saliba, Shawn Baldacchino, James Degaetano, Joseph Debono, Gordon Caruana-Dingli, Godfrey Grech, Christian Scerri, Giovanni Tesoriere, Antonio Giordano, Renza Vento, and Riccardo Di Fiore
Oncotarget. 2017 April 25;8(17):28939-58
PMID: 28423652
Paola Palumbo, Gianfranca Miconi, Benedetta Cinque, Francesca Lombardi, Cristina La Torre, Soheila Raysi Dehcordi, Renato Galzio, Annamaria Cimini, Antonio Giordano, and Maria Grazia Cifone
Oncotarget. 2017 April 11;8(15):25582-98
PMID: 28424427
Ying Pang, Chunzhang Yang, Jan Schovanek, Herui Wang, Petra Bullova, Veronika Caisova, Garima Gupta, Katherine I. Wolf, Gregg L. Semenza, Zhengping Zhuang, and Karel Pacak
Oncotarget. 2017 April 4;8(14):22313-24
PMID: 28423608
MicroRNAs in melanoma development and resistance to target therapy.
Luigi Fattore, Susan Costantini, Debora Malpicci, Ciro Francesco Ruggiero, Paolo Antonio Ascierto, Carlo M. Croce, Rita Mancini, and Gennaro Ciliberto
Oncotarget. 2017 March 28;8(13):22262-78
PMID: 28118616
Gloria Bonuccelli, Ernestina Marianna De Francesco, Rianne de Boer, Herbert B. Tanowitz, and Michael P. Lisanti
Oncotarget. 2017 March 28;8(13):20667-78
PMID: 28223550
Marco Fiorillo, Federica Sotgia, Diego Sisci, Anna Rita Cappello, and Michael P. Lisanti
Oncotarget. 2017 March 21;8(12):20309-27
PMID: 28411284
Kevin Watanabe-Smith, Jamila Godil, Anupriya Agarwal, Cristina Tognon, and Brian Druker
Oncotarget. 2017 February 21;8(8):12596-606
PMID: 28208123
Giorgio Malpeli, Stefano Barbi, Simonetta Zupo, Gabriele Tosadori, Giovanni Scardoni, Anna Bertolaso, Silvia Sartoris, Stefano Ugel, Caterina Vicentini, Matteo Fassan, Annalisa Adamo, Mauro Krampera, Maria Teresa Scupoli, Carlo Maria Croce, and Aldo Scarpa
Oncotarget. 2017 February 14;8(7):11809-26
PMID: 28107180
The RNA-binding protein ESRP1 promotes human colorectal cancer progression.
Sharmila Fagoonee, Gabriele Picco, Francesca Orso, Arrigo Arrigoni, Dario L. Longo, Marco Forni, Irene Scarfò, Adele Cassenti, Roberto Piva, Paola Cassoni, Lorenzo Silengo, Emanuela Tolosano, Silvio Aime, Daniela Taverna, Pier Paolo Pandolfi, Mara Brancaccio, Enzo Medico, and Fiorella Altruda
Oncotarget. 2017 February 7;8(6):10007-24
PMID: 28052020
Gloria Bonuccelli, Maria Peiris-Pagès, Bela Ozsvari, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2017 February 7;8(6):9868-84
PMID: 28039467
Metformin: a metabolic modulator.
Federico Pietrocola, and Guido Kroemer
Oncotarget. 2017 February 7;8(6):9017-20
PMID: 28122334
Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Caterina Fanizza, Antonino Scimone, Giuseppe Chiofalo, Antonio Giordano, and Vincenzo Adamo
Oncotarget. 2017 January 31;8(5):8717-25
PMID: 28060728
miR-494-3p is a novel tumor driver of lung carcinogenesis.
Alice Faversani, Stefano Amatori, Claudia Augello, Federico Colombo, Laura Porretti, Mirco Fanelli, Stefano Ferrero, Alessandro Palleschi, Pier Giuseppe Pelicci, Elena Belloni, Giulia Ercoli, Anna Degrassi, Marco Baccarin, Dario C. Altieri, Valentina Vaira, and Silvano Bosari
Oncotarget. 2017 January 31;8(5):7231-47
PMID: 27980227
Arnold J. Levine
Oncotarget. 2017 January 31;8(5):7228-30
PMID: 28129641
Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.
Guido Kroemer, and Lorenzo Galluzzi
Oncotarget. 2017 January 24;8(4):5686-91
PMID: 27974686
Hsien-Ming Wu, Hong-Yuan Huang, Andrew V. Schally, Angel Chao, Hung-Hsueh Chou, Peter C.K. Leung, and Hsin-Shih Wang
Oncotarget. 2017 January 17;8(3):4410-21
PMID: 28032599
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.
Chiara D’Avino, Dario Palmieri, Ashley Braddom, Nicola Zanesi, Cindy James, Sara Cole, Francesco Salvatore, Carlo M. Croce, and Claudia De Lorenzo
Oncotarget. 2016 December 27;7(52):87016-30
PMID: 27894092
HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation.
Luigi Alfano, Caterina Costa, Antonella Caporaso, Dario Antonini, Antonio Giordano, and Francesca Pentimalli
Oncotarget. 2016 November 22;7(47):78127-39
PMID: 27816966
Apoptosis inducing factor (AIF) mediates lethal redox stress induced by menadione.
Hesti Lina Wiraswati, Emilie Hangen, Ana Belén Sanz, Ngoc-Vy Lam, Camille Reinhardt, Allan Sauvat, Ariane Mogha, Alberto Ortiz, Guido Kroemer, and Nazanine Modjtahedi
Oncotarget. 2016 November 22;7(47):76496-507
PMID: 27738311
Lei Wei, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, May Elbanna, Jianmin Wang, Qiang Hu, Sean T. Glenn, Mitsuko Murakami, Lu Liu, Eduardo Cortes Gomez, Yuchen Sun, Jacob Conroy, Kiersten Marie Miles, Kullappan Malathi, Sudha Ramaiah, Anand Anbarasu, Anna Woloszynska-Read, Candace S. Johnson, Jeffrey Conroy, Song Liu, Carl D. Morrison, and Roberto Pili
Oncotarget. 2016 November 22;7(47):76374-89
PMID: 27823983
Discovery and clinical introduction of first-in-class imipridone ONC201.
Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa, Neel Madhukar, Avital Lev, Marie Baumeister, Lanlan Zhou, Amriti Lulla, Martin Stogniew, Lee Schalop, Cyril Benes, Howard L. Kaufman, Richard S. Pottorf, B. Rao Nallaganchu, Gary L. Olson, Fahd Al-Mulla, Madeleine Duvic, Gen Sheng Wu, David T. Dicker, Mala K. Talekar, Bora Lim, Olivier Elemento, Wolfgang Oster, Joseph Bertino, Keith Flaherty, Michael L. Wang, Gautam Borthakur, Michael Andreeff, Mark Stein, and Wafik S. El-Deiry
Oncotarget. 2016 November 8;7(45):74380-92
PMID: 27602582
Nélida Inés Noguera, Maria Liliana Piredda, Riccardo Taulli, Gianfranco Catalano, Giulia Angelini, Girish Gaur, Clara Nervi, Maria Teresa Voso, Andrea Lunardi, Pier Paolo Pandolfi, and Francesco Lo-Coco
Oncotarget. 2016 October 11;7(41):66386-97
PMID: 27626703
Chuanzhao Zhang, Wanqing Iris Zhi, Haiquan Lu, Debangshu Samanta, Ivan Chen, Edward Gabrielson, and Gregg L. Semenza
Oncotarget. 2016 October 4;7(40):64527-42
PMID: 27590511
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.
Lynsey Vaughan, Paul A. Clarke, Karen Barker, Yvan Chanthery, Clay W. Gustafson, Elizabeth Tucker, Jane Renshaw, Florence Raynaud, Xiaodun Li, Rosemary Burke, Yann Jamin, Simon P. Robinson, Andrew Pearson, Michel Maira, William A. Weiss, Paul Workman, and Louis Chesler
Oncotarget. 2016 September 6;7(36):57525-44
PMID: 27438153
Pier Paolo Leoncini, Alice Bertaina, Dimitrios Papaioannou, Christian Flotho, Riccardo Masetti, Silvia Bresolin, Giuseppe Menna, Nicola Santoro, Marco Zecca, Giuseppe Basso, Giovanni Nigita, Dario Veneziano, Sara Pagotto, Katia D’Ovidio, Rossella Rota, Adrienne Dorrance, Carlo M. Croce, Charlotte Niemeyer, Franco Locatelli, and Ramiro Garzon
Oncotarget. 2016 August 23;7(34):55395-408
PMID: 27447965
Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias.
Arash Sattari, Hasan Siddiqui, Farzaneh Moshiri, Apollinaire Ngankeu, Tatsuya Nakamura, Thomas J. Kipps, and Carlo M. Croce
Oncotarget. 2016 August 23;7(34):54174-82
PMID: 27527866
Tengjiao Cui, Joaquin J. Jimenez, Norman L. Block, Evangelos V. Badiavas, Luis Rodriguez-Menocal, Ailin Vila Granda, Renzhi Cai, Wei Sha, Marta Zarandi, Roberto Perez, and Andrew V. Schally
Oncotarget. 2016 August 16;7(33):52661-72
PMID: 27494841
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
Aejaz Sayeed, Huimin Lu, Qin Liu, David Deming II, Alexander Duffy, Peter McCue, Adam P. Dicker, Roger J. Davis, Dmitry Gabrilovich, Ulrich Rodeck, Dario C. Altieri, and Lucia R. Languino
Oncotarget. 2016 August 16;7(33):52618-30
PMID: 27438371
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer.
Laura Muñoz-Moreno, M. Isabel Arenas, María J. Carmena, Andrew V. Schally, Manuel Sánchez-Chapado, Juan C. Prieto, and Ana M. Bajo
Oncotarget. 2016 August 9;7(32):52195-206
PMID: 27448980
Gianmaria Miolo, Elena Muraro, Donatella Caruso, Diana Crivellari, Anthony Ash, Simona Scalone, Davide Lombardi, Flavio Rizzolio, Antonio Giordano, and Giuseppe Corona
Oncotarget. 2016 June 28;7(26):39809-22.
PMID: 27223427
Christophe Le Clorennec, Yassamine Lazrek, Olivier Dubreuil, Christel Larbouret, Marie-Alix Poul, Philippe Mondon, Gerry Melino, André Pèlegrin, and Thierry Chardès
Oncotarget. 2016 June 14;7(24):37013-29.
PMID: 27203743
Marco Fiorillo, Rebecca Lamb, Herbert B. Tanowitz, Luciano Mutti, Marija Krstic-Demonacos, Anna Rita Cappello, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2016 June 7;7(23):34084-99.
PMID: 27136895
Masahiro Matsubara, and Mina J. Bissell
Oncotarget. 2016 May 31;7(22):31602-22.
PMID: 27203208
Tanupriya Contractor, Shinta Kobayashi, Edaise da Silva, Richard Clausen, Chang Chan, Evan Vosburgh, Laura H. Tang, Arnold J. Levine, and Chris R. Harris
Oncotarget. 2016 May 24;7(21):30585-96.
PMID: 27105526
Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes.
Lia R. Edmunds, P. Anthony Otero, Lokendra Sharma, Sonia D’Souza, James M. Dolezal, Sherin David, Jie Lu, Lauren Lamm, Mahesh Basantani, Pili Zhang, Ian J. Sipula, Lucy Li, Xuemei Zeng, Ying Ding, Fei Ding, Megan E. Beck, Jerry Vockley, Satdarshan P. S. Monga, Erin E. Kershaw, Robert M. O’Doherty, Lisa E. Kratz, Nathan A. Yates, Eric P. Goetzman, Donald Scott, Andrew W. Duncan, and Edward V. Prochownik
Oncotarget. 2016 May 24;7(21):30379-95.
PMID: 27105497
Eugenio Gaudio, Francesco Paduano, Apollinaire Ngankeu, Francesco Ortuso, Francesca Lovat, Sandra Pinton, Sabrina D’Agostino, Nicola Zanesi, Rami I. Aqeilan, Pietro Campiglia, Ettore Novellino, Stefano Alcaro, Carlo M. Croce, and Francesco Trapasso
Oncotarget. 2016 May 24;7(21):29927-36.
PMID: 27166255
Metabolic pathways regulated by TAp73 in response to oxidative stress.
Massimiliano Agostini, Margherita Annicchiarico-Petruzzelli, Gerry Melino, and Alessandro Rufini
Oncotarget. 2016 May 24;7(21):29881-900.
PMID: 27119504
Metabolic vulnerabilities of MYC-induced cancer.
Arvin M. Gouw, Georgia G. Toal, and Dean W. Felsher
Oncotarget. 2016 May 24;7(21):29879-80.
PMID: 26863454
Amino acid deprivation promotes intestinal homeostasis through autophagy.
Lorenzo Galluzzi, and Guido Kroemer
Oncotarget. 2016 May 24;7(21):29877-78.
PMID: 27105494
Chromatin dysregulation by mutant p53.
Neil T. Pfister, and Carol Prives
Oncotarget. 2016 May 24;7(21):29875-76.
PMID: 27127877
Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis.
Carla Regina, Mirco Compagnone, Angelo Peschiaroli, AnnaMaria Lena, Margherita Annicchiarico-Petruzzelli, Maria Cristina Piro, Gerry Melino, and Eleonora Candi
Oncotarget. 2016 May 17;7(20):28836-48.
PMID: 26840455
Daniele Fanale, Valeria Amodeo, Viviana Bazan, Lavinia Insalaco, Lorena Incorvaia, Nadia Barraco, Marta Castiglia, Sergio Rizzo, Daniele Santini, Antonio Giordano, Sergio Castorina, and Antonio Russo
Oncotarget. 2016 May 17;7(20):29321-32.
PMID: 27081088
Yulin Li, Anja Deutzmann, Peter S. Choi, Alice C. Fan, and Dean W. Felsher
Oncotarget. 2016 May 10;7(19):26926-34.
PMID: 27095570
Antonio Viúdez, Filipe L.F. Carvalho, Zahra Maleki, Marianna Zahurak, Daniel Laheru, Alejandro Stark, Nilofer Z. Azad, Christopher L. Wolfgang, Stephen Baylin, James G. Herman, and Ana De Jesus-Acosta
Oncotarget. 2016 May 3;7(18):24950-61.
PMID: 26894863
Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth.
Zsuzsanna Nemeth, Eva Csizmadia, Lisa Vikstrom, Mailin Li, Kavita Bisht, Alborz Feizi, Sherrie Otterbein, Brian Zuckerbraun, Daniel B. Costa, Pier Paolo Pandolfi, Janos Fillinger, Balazs Döme, Leo E. Otterbein, and Barbara Wegiel
Oncotarget. 2016 April 26;7(17):23919-32.
PMID: 26993595
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors.
Matteo Rossi, David Colecchia, Gennaro Ilardi, Mario Acunzo, Giovanni Nigita, Federica Sasdelli, Angela Celetti, Angela Strambi, Stefania Staibano, Carlo Maria Croce, and Mario Chiariello
Oncotarget. 2016 April 12;7(15):20981-98.
PMID: 26988910
Joanna Kopecka, Stefania Porto, Sara Lusa, Elena Gazzano, Giuseppina Salzano, Martha Leonor Pinzòn-Daza, Antonio Giordano, Vincenzo Desiderio, Dario Ghigo, Giuseppe De Rosa, Michele Caraglia, and Chiara Riganti
Oncotarget. 2016 April 12;7(15):20753-72.
PMID: 26980746
Danilo Fiore, Elvira Donnarumma, Giuseppina Roscigno, Margherita Iaboni, Valentina Russo, Alessandra Affinito, Assunta Adamo, Fabio De Martino, Cristina Quintavalle, Giulia Romano, Adelaide Greco, Ylermi Soini, Arturo Brunetti, Carlo M. Croce, and Gerolama Condorelli
Oncotarget. 2016 April 12;7(15):19531-47.
PMID: 26799668
Dario Palmieri, Mario Scarpa, Anna Tessari, Rexhep Uka, Foued Amari, Cindy Lee, Timothy Richmond, Claudia Foray, Tyler Sheetz, Ashley Braddom, Christin E. Burd, Jeffrey D. Parvin, Thomas Ludwig, Carlo M. Croce, and Vincenzo Coppola
Oncotarget. 2016 April 5;7(14):18371-83.
PMID: 26943034
Sangwoon Chung, Tae Jin Lee, Brenda F. Reader, Ji Young Kim, Yong Gyu Lee, Gye Young Park, Manjula Karpurapu, Megan N. Ballinger, Feng Qian, Luiza Rusu, Hae Young Chung, Terry G. Unterman, Carlo M. Croce, and John W. Christman
Oncotarget. 2016 April 5;7(14):17532-46.
PMID: 27007158
Han Han, Yuxing Chen, Li Cheng, Edward V. Prochownik, and Youjun Li
Oncotarget. 2016 March 29;7(13):16409-19.
PMID: 26918941
p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression.
Vivien Landré, Alexey Antonov, Richard Knight, and Gerry Melino
Oncotarget. 2016 March 15;7(11):111785-802.
PMID: 26930720
Louise Y. Fong, Cristian Taccioli, Ruiyan Jing, Karl J. Smalley, Hansjuerg Alder, Yubao Jiang, Paolo Fadda, John L. Farber, and Carlo M. Croce
Oncotarget. 2016 March 8;7(10):10723-38.
PMID: 26918602
Ke Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, Monika Deshpande, Brooks Puchner, Fabiana Kashiwabuchi, Syed Junaid Hassan, Laura Asnaghi, James T. Handa, Shannath Merbs, Charles G. Eberhart, Gregg L. Semenza, Silvia Montaner, and Akrit Sodhi
Oncotarget. 2016 Feb 16;7(7):7816-28.
PMID: 26761211
Philip M. Tedeschi, Kathleen W. Scotto, John Kerrigan, and Joseph R. Bertino
Oncotarget. 2016 Feb 16;7(7):7368-69.
PMID: 26848977
Paula de Melo Campos, João A. Machado-Neto, Christopher A. Eide, Samantha L. Savage, Renata Scopim-Ribeiro, Adriana da Silva Souza Duarte, Patricia Favaro, Irene Lorand-Metze, Fernando F. Costa, Cristina E. Tognon, Brian J. Druker, Sara T. Olalla Saad, and Fabiola Traina
Oncotarget. 2016 Feb 9;7(6):6948-59.
PMID: 26755644
Weibo Luo, Ivan Chen, Yan Chen, Duah Alkam, Yingfei Wang, and Gregg L. Semenza
Oncotarget. 2016 Feb 9;7(6):6379-97.
PMID: 26837221
CEST theranostics: label-free MR imaging of anticancer drugs.
Yuguo Li, Hanwei Chen, Jiadi Xu, Nirbhay N. Yadav, Kannie W. Y. Chan, Liangping Luo, Michael T. McMahon, Bert Vogelstein, Peter C.M. van Zijl, Shibin Zhou, and Guanshu Liu
Oncotarget. 2016 Feb 9;7(6):6369-78.
PMID: 26837220
Emiliana Perillo, Stefania Porto, Annarita Falanga, Silvia Zappavigna, Paola Stiuso, Virginia Tirino, Vincenzo Desiderio, Gianpaolo Papaccio, Massimiliano Galdiero, Antonio Giordano, Stefania Galdiero, and Michele Caraglia
Oncotarget. 2016 Jan 26;7(4):4077-92.
PMID: 26554306
Elizabeth M. Matthew, Lanlan Zhou, Zhaohai Yang, David T. Dicker, Sheldon L. Holder, Bora Lim, Ramdane Harouaka, Si-Yang Zheng, Joseph J. Drabick, Nicholas E. Lamparella, Cristina I. Truica, and Wafik S. El-Deiry
Oncotarget. 2016 Jan 26;7(4):3662-76.
PMID: 26695546
Blocking the survival of the nastiest by HSP90 inhibition.
Paul Workman, Paul A. Clarke, and Bissan Al-Lazikani
Oncotarget. 2016 Jan 26;7(4):3658-61.
PMID: 26820296
Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.
Mohamed Jemaà, Gwenola Manic, Gwendaline Lledo, Delphine Lissa, Christelle Reynes, Nathalie Morin, Frédéric Chibon, Antonella Sistigu, Maria Castedo, Ilio Vitale, Guido Kroemer, and Ariane Abrieu
Oncotarget. 2016 Jan 5;7(1):885-901.
PMID: 26637805
Alessandra Cataldo, Douglas G. Cheung, Andrea Balsari, Elda Tagliabue, Vincenzo Coppola, Marilena V. Iorio, Dario Palmieri, and Carlo M. Croce
Oncotarget. 2016 Jan 5;7(1):786-97.
PMID: 26623722
Yang Zhang, Xiaoai Zhang, Hongxing Zhang, Yun Zhai, Zhifu Wang, Peiyao Li, Lixia Yu, Xia Xia, Ying Zhang, Yixin Zeng, Fuchu He, and Gangqiao Zhou
Oncotarget. 2016 Jan 5;7(1):759-70.
PMID: 26621837
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Giuseppina Roscigno, Cristina Quintavalle, Elvira Donnarumma, Ilaria Puoti, Angel Diaz-Lagares, Margherita Iaboni, Danilo Fiore, Valentina Russo, Matilde Todaro, Giulia Romano, Renato Thomas, Giuseppina Cortino, Miriam Gaggianesi, Manel Esteller, Carlo M. Croce, and Gerolama Condorelli
Oncotarget. 2016 Jan 5;7(1):580-92.
PMID: 26556862
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Pier Paolo Piccaluga, Mohsen Navari, Giulia De Falco, Maria Raffaella Ambrosio, Stefano Lazzi, Fabio Fuligni, Cristiana Bellan, Maura Rossi, Maria Rosaria Sapienza, Maria Antonella Laginestra, Maryam Etebari, Emily A. Rogena, Lynnette Tumwine, Claudio Tripodo, Davide Gibellini, Jessica Consiglio, Carlo M. Croce, Stefano A. Pileri, and Lorenzo Leoncini
Oncotarget. 2016 Jan 5;7(1):224-40.
PMID: 26325594
Chen Li Chew, Ming Chen, Pier Paolo Pandolfi
Oncotarget. 2016 Jan 5;7(1):5-6.
PMID: 26700619
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling.
Laura Brandolini, Loredana Cristiano, Alessia Fidoamore, Maria De Pizzol, Erica Di Giacomo, Tiziana Marilena Florio, Giuseppina Confalone, Angelo Galante, Benedetta Cinque, Elisabetta Benedetti, Pier Adelchi Ruffini, Maria Grazia Cifone, Antonio Giordano, Marcello Alecci, Marcello Allegretti, and Annamaria Cimini
Oncotarget. 2015 Dec 22;6(41):43375-94.
PMID: 26517518
Mark Duquette, Peter M. Sadow, Amjad Husain, Jennifer N. Sims, Zeus A. Antonello, Andrew H. Fischer, Chen Song, Elena Castellanos-Rizaldos, G. Mike Makrigiorgos, Junichi Kurebayashi, Vania Nose, Paul Van Hummelen, Roderick T. Bronson, Michelle Vinco, Thomas J. Giordano, Dora Dias-Santagata, Pier Paolo Pandolfi, and Carmelo Nucera
Oncotarget. 2015 Dec 15;6(40):42445-67.
PMID: 26636651
Elisabetta Benedetti, Andrea Antonosante, Michele d’Angelo, Loredana Cristiano, Renato Galzio, Damien Destouches, Tiziana Marilena Florio, Anne Chloé Dhez, Carlo Astarita, Benedetta Cinque, Alessia Fidoamore, Floriana Rosati, Maria Grazia Cifone, Rodolfo Ippoliti, Antonio Giordano, José Courty, and Annamaria Cimini.
Oncotarget. 2015 Dec 8;6(39):42091-104.
PMID: 26540346
Morphometric analysis of immunoselection against hyperploid cancer cells.
Norma Bloy, Allan Sauvat, Kariman Chaba, Aitziber Buqué, Juliette Humeau, José Manuel Bravo-San Pedro, Jack Bui, Oliver Kepp, Guido Kroemer, and Laura Senovilla.
Oncotarget. 2015 Dec 1;6(38):41204-15.
PMID: 26517677
Defective autophagy gets to the brain.
Lorenzo Galluzzi, and Guido Kroemer.
Oncotarget. 2015 Nov 24;6(37):39396-7.
PMID: 26575951
Brent H. Koehn, Robert Zeiser, and Bruce R. Blazar.
Oncotarget. 2015 Nov 17;6(36):38444-5.
PMID: 26564963
Q-ing tumor glutaminase for therapy.
Zachary E. Stine, and Chi V. Dang.
Oncotarget. 2015 Nov 17;6(36):38440-1.
PMID: 26564960
p73 regulates basal and starvation-induced liver metabolism in vivo.
Zhaoyue He, Massimiliano Agostini, He Liu, Gerry Melino, and Hans-Uwe Simon.
Oncotarget. 2015 Oct 20;6(32):33178-90.
PMID: 26375672
Marco Agostini, Klaus-Peter Janssen, Il-Jin Kim, Edoardo D’Angelo, Silvia Pizzini, Andrea Zangrando, Carlo Zanon, Chiara Pastrello, Isacco Maretto, Maura Digito, Chiara Bedin, Igor Jurisica, Flavio Rizzolio, Antonio Giordano, Stefania Bortoluzzi, Donato Nitti, and Salvatore Pucciarelli.
Oncotarget. 2015 Oct 20;6(32):32561-74.
PMID: 26359356
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.
Huabo Wang, Peter Teriete, Angela Hu, Dhanya Raveendra-Panickar, Kelsey Pendelton, John S. Lazo, Julie Eiseman, Toril Holien, Kristine Misund, Ganna Oliynyk, Marie Arsenian-Henriksson, Nicholas D. P. Cosford, Anders Sundan, and Edward V. Prochownik.
Oncotarget. 2015 Oct 20;6(32):32380-95.
PMID: 26474287
Joanna Kopecka, Stefania Porto, Sara Lusa, Elena Gazzano, Giuseppina Salzano, Antonio Giordano, Vincenzo Desiderio, Dario Ghigo, Michele Caraglia, Giuseppe De Rosa, and Chiara Riganti.
Oncotarget. 2015 Oct 13;6(31):31461-78.
PMID: 26372812
Gillian Farnie, Federica Sotgia, and Michael P. Lisanti.
Oncotarget. 2015 Oct 13;6(31):30472-86.
PMID: 26421710
Rebecca Lamb, Gloria Bonuccelli, Béla Ozsvári, Maria Peiris-Pagès, Marco Fiorillo, Duncan L. Smith, Generoso Bevilacqua, Chiara Maria Mazzanti, Liam A. McDonnell, Antonio Giuseppe Naccarato, Maybo Chiu, Luke Wynne, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, and Michael P. Lisanti.
Oncotarget. 2015 Oct 13;6(31):30453-71.
PMID: 26421711
Maria Rita Pitari, Marco Rossi, Nicola Amodio, Cirino Botta, Eugenio Morelli, Cinzia Federico, Annamaria Gullà, Daniele Caracciolo, Maria Teresa Di Martino, Mariamena Arbitrio, Antonio Giordano, Pierosandro Tagliaferri, Pierfrancesco Tassone.
Oncotarget. 2015 Sep 29;6(29):27343-58.
PMID: 26160841
Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Antonio Picone, Giuseppa Ferraro, Mariangela Zanghì, Giuseppe Toscano, Antonio Giordano, and Vincenzo Adamo.
Oncotarget. 2015 Sep 29;6(29):26814-25.
PMID: 26308162
Heng Zhou, Sabrina Forveille, Allan Sauvat, Valentina Sica, Valentina Izzo, Sylvère Durand, Kevin Müller, Peng Liu, Laurence Zitvogel, Øystein Rekdal, Oliver Kepp, and Guido Kroemer.
Oncotarget. 2015 Sep 29;6(29):26599-614.
PMID: 26378049
Triple negative breast cancer: looking for the missing link between biology and treatments
Giuseppe Palma, Giuseppe Frasci, Andrea Chirico, Emanuela Esposito, Claudio Siani, Carmela Saturnino, Claudio Arra, Gennaro Ciliberto, Antonio Giordano, and Massimiliano D’Aiuto.
Oncotarget. 2015 Sep 29;6(29):26560-74.
PMID: 26387133
KMT Set7/9 affects genotoxic stress response via the Mdm2 axis
Larissa Lezina, Vasilisa Aksenova, Olga Fedorova, Daria Malikova, Oleg Shuvalov, Alexey V. Antonov, Dmitri Tentler, Alexander V. Garabadgiu, Gerry Melino, and Nikolai A. Barlev.
Oncotarget. 2015 Sep 22;6(28):25843-55.
PMID: 26317544
Ivan Casaburi, Paola Avena, Arianna De Luca, Adele Chimento, Rosa Sirianni, Rocco Malivindi, Vittoria Rago, Marco Fiorillo, Francesco Domanico, Carmela Campana, Anna Rita Cappello, Federica Sotgia, Michael P. Lisanti, and Vincenzo Pezzi.
Oncotarget. 2015 Sep 22;6(28):25135-48.
PMID: 26312764
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia, Antonio Galvano, Francesco Passiglia, Giovanni Sortino, Giuseppe Cicero, Christian Rolfo, Marc Peeters, Viviana Bazan, Daniele Fanale, Antonio Giordano, and Antonio Russo.
Oncotarget. 2015 Sep 22;6(28):24780-96.
PMID: 26318427
The 26S proteasome is a multifaceted target for anti-cancer therapies.
Tatyana A. Grigoreva, Vyacheslav G. Tribulovich, Alexander V. Garabadzhiu, Gerry Melino, and Nickolai A. Barlev.
Oncotarget. 2015 Sep 22;6(28):24733-49.
PMID: 26295307
Quaking and miR-155 interactions in inflammation and leukemogenesis.
Esmerina Tili, Marcela Chiabai, Dario Palmieri, Melissa Brown, Ri Cui, Cecilia Fernandes, Tim Richmond, Taewan Kim, Tyler Sheetz, Hui-Lung Sun, Alessandro Lagana, Dario Veneziano, Stefano Volinia, Laura Rassenti, Thomas Kipps, Hamdy Awad, Jean-Jacques Michaille, and Carlo M. Croce.
Oncotarget. 2015 Sep 22;6(28):24599-610.
PMID: 26337206
Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.
Michael W. Pickup, Laura D. Hover, Yan Guo, Agnieszka E. Gorska, Anna Chytil, Sergey V. Novitskiy, Harold L. Moses and Philip Owens.
Oncotarget. 2015 Sep 8;6(26):22890-904
PMID: 26274893
Rebecca Lamb, Bela Ozsvari, Gloria Bonuccelli, Duncan L. Smith, Richard G. Pestell, Ubaldo E. Martinez-Outschoorn, Robert B. Clarke, Federica Sotgia, and Michael P. Lisanti.
Oncotarget. 2015 Sep 8;6(26):21892-905.
PMID: 26323205
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.
Ri Cui, Taewan Kim, Matteo Fassan, Wei Meng, Hui-Lung Sun, Young-Jun Jeon, Caterina Vicentini, Esmerina Tili, Yong Peng, Aldo Scarpa, Guang Liang, Yong Kui Zhang, Arnab Chakravarti, and Carlo M. Croce.
Oncotarget. 2015 Sep 8;6(26):21802-15.
PMID: 26307684
Erika Vacchelli, Michaela Semeraro, David P. Enot, Kariman Chaba, Vichnou Poirier Colame, Peggy Dartigues, Aurelie Perier, Irene Villa, Sylvie Rusakiewicz, Caroline Gronnier, Diane Goéré, Christophe Mariette, Laurence Zitvogel, and Guido Kroemer.
Oncotarget. 2015 Aug 28;6(25):20840-50.
PMID: 26369701
Alessandra Drusco, Arianna Bottoni, Alessandro Laganà, Mario Acunzo, Matteo Fassan, Luciano Cascione, Anna Antenucci, Prasanthi Kumchala, Caterina Vicentini, Marina P. Gardiman, Hansjuerg Alder, Mariantonia A. Carosi, Mario Ammirati, Stefano Gherardi, Marilena Luscrì, Carmine Carapella, Nicola Zanesi, Carlo M. Croce.
Oncotarget. 2015 Aug 28;6(25):20829-39
PMID: 26246487
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.
Antonella Bresin, Elisa Callegari, Lucilla D’Abundo, Caterina Cattani, Cristian Bassi, Barbara Zagatti, M. Grazia Narducci, Elisabetta Caprini, Yuri Pekarsky, Carlo M. Croce, Silvia Sabbioni, Giandomenico Russo and Massimo Negrini.
Oncotarget. 2015 Aug 28;6(25):19807-18
PMID: 26090867
Matthew B. Siegel, Selina Qiuying Liu, Monika A. Davare, Stephen E. Spurgeon, Marc M. Loriaux, Brian J. Druker, Emma C. Scott, and Jeffrey W. Tyner.
Oncotarget. 2015 Aug 7;6(22):18921-32
PMID: 26254279
Taewan Kim, Ri Cui, Young-Jun Jeon, Paolo Fadda, Hansjuerg Alder, Carlo M. Croce.
Oncotarget. 2015 Aug 7;6(22):18780-9
PMID: 26003165
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
Paola Indovina, Francesca Pentimalli, Nadia Casini, Immacolata Vocca, Antonio Giordano.
Oncotarget. 2015 Jul 20;6(20):17873-90. Review.
PMID: 26160835
Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.
Lucilla Bongiorno-Borbone, Arianna Giacobbe, Mirco Compagnone, Adriana Eramo, Ruggero De Maria, Angelo Peschiaroli, and Gerry Melino.
Oncotarget. 2015 Jul 10;6(19):16926-38.
PMID: 26219257
Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion.
Huabo Wang, Lokendra Sharma, Jie Lu, Paul Finch, Steven Fletcher, and Edward V. Prochownik.
Oncotarget. 2015 Jun 30;6(18):15857-70.
PMID: 26036281
Arianna De Luca, Marco Fiorillo, Maria Peiris-Pagès, Bela Ozsvari, Duncan L. Smith, Rosa Sanchez-Alvarez, Ubaldo E. Martinez-Outschoorn, Anna Rita Cappello, Vincenzo Pezzi, Michael P. Lisanti, and Federica Sotgia
Oncotarget. 2015 Jun 20;6(17):14777-95.
PMID: 26087310
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Tae Jin Lee, Farzin Haque, Dan Shu, Ji Young Yoo, Hui Li, Robert A. Yokel, Craig Horbinski, Tae Hyong Kim, Sung-Hak Kim, Chang-Hyuk Kwon, Ichiro Nakano, Balveen Kaur, Peixuan Guo, Carlo M. Croce.
Oncotarget. 2015 Jun 20;6(17):14766-76.
PMID: 25885522
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
Nitu Bansal, Prasun J. Mishra, Mark Stein, Robert S. DiPaola and Joseph R. Bertino.
Oncotarget. 2015 Jun 20;6(17):15321-31.
PMID: 26036314
Rebecca Ward, Andrew H. Sims, Alexander Lee, Christina Lo, Luke Wynne, Humza Yusuf, Hannah Gregson, Michael P. Lisanti, Federica Sotgia, Göran Landberg, and Rebecca Lamb.
Oncotarget. 2015 Jun 10;6(16):14687-99.
PMID: 26008983
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.
Marco Trerotola, Kirat K. Ganguly, Ladan Fazli, Carmine Fedele, Huimin Lu, Anindita Dutta, Qin Liu, Tiziana De Angelis, Luke W. Riddell, Natalia A. Riobo, Martin E. Gleave, Amina Zoubeidi, Richard G. Pestell, Dario C. Altieri, and Lucia R. Languino.
Oncotarget. 2015 Jun 10;6(16):14318-28.
PMID: 26015409
Rebecca Lamb, Marco Fiorillo, Amy Chadwick, Bela Ozsvari, Kimberly J. Reeves, Duncan L. Smith, Robert B. Clarke, Sacha J. Howell, Anna Rita Cappello, Ubaldo E. Martinez-Outschoorn, Maria Peiris-Pagès, Federica Sotgia, and Michael P. Lisanti.
Oncotarget. 2015 Jun 10;6(16):14005-25.
PMID: 26087309
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
Lisha Xiang, Daniele M. Gilkes, Hongxia Hu, Weibo Luo, John W. Bullen, Houjie Liang and Gregg L. Semenza.
Oncotarget. 2015 May 20;6(14):11768-78.
PMID: 26059435
Loss of Wave1 gene defines a subtype of lethal prostate cancer.
Adam G. Sowalsky, Rebecca Sager, Rachel J. Schaefer, Gennady Bratslavsky, Pier Paolo Pandolfi, Steven P. Balk, Leszek Kotula.
Oncotarget. 2015 May 20;6(14):12383-91.
PMID: 25906751
Gautier Stoll, Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon, Laurence Zitvogel, and Guido Kroemer.
Oncotarget. 2015 May 20;6(14):11894-909.
PMID: 26059437
Nadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, Francesca Pentimalli, Adriano Angelucci, Claudio Festuccia, Valentina Tomei, Elisa Ceccherini, Domenico Di Marzo, Silvia Schenone, Maurizio Botta, Antonio Giordano, Paola Indovina.
Oncotarget. 2015 May 20;6(14):12421-35.
PMID: 25762618
Jessica Frankum, Pavel Moudry, Rachel Brough, Zdenek Hodny, Alan Ashworth, Jiri Bartek, and Christopher J. Lord
Oncotarget. 2015 May 10;6(13):10746-58.
PMID: 25883215
Maria Peiris-Pagès, Federica Sotgia, and Michael P. Lisanti
Oncotarget. 2015 May 10;6(13):10728-45.
PMID: 25915429
Rosemeire M. Kanashiro-Takeuchi, Luca Szalontay, Andrew V. Schally, Lauro M. Takeuchi, Petra Popovics, Miklos Jaszberenyi, Irving Vidaurre, Marta Zarandi, Ren-Zhi Cai, Norman L. Block, Joshua M. Hare, Ferenc G. Rick,
Oncotarget. 2015 Apr 30;6(12):9728-39.
PMID: 25797248
Polypharmacology of small molecules targeting the ubiquitin–proteasome and ubiquitin-like systems.
Ivano Amelio, Vivien Landré, Richard A. Knight, Andrey Lisitsa, Gerry Melino, and Alexey V. Antonov
Oncotarget. 2015 Apr 30;6(12):9646-56.
PMID: 25991664
Deregulation of dicer and mir-155 expression in liposarcoma.
Bruno Vincenzi, Michele Iuliani, Alice Zoccoli, Francesco Pantano, Marco Fioramonti, Delia De Lisi, Anna Maria Frezza, Carla Rabitti, Giuseppe Perrone, Andrea Onetti Muda, Antonio Russo, Antonio Giordano, Daniele Santini, Angelo Paolo Dei Tos, Giuseppe Tonini.
Oncotarget. 2015 Apr 30;6(12):10586-91.
PMID: 25888631
Quantification of cellular viability by automated microscopy and flow cytometry.
Allan Sauvat, Yidan Wang, Florian Segura, Sabrina Spaggiari, Kevin Müller, Heng Zhou, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Oncotarget. 2015 Apr 20;6(11):9467-75.
PMID: 25816366
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.
Mathew C. Casimiro, Gabriele Di Sante, Marco Crosariol, Emanuele Loro, William Dampier, Adam Ertel, Zuoren Yu, Elizabeth A. Saria, Alexandros Papanikolaou, Zhiping Li, Chenguang Wang, Sankar Addya, Michael P. Lisanti, Paolo Fortina, Robert D. Cardiff, Aydin Tozeren, Erik S. Knudsen, Andrew Arnold, and Richard G. Pestell
Oncotarget. 2015 Apr 20;6(11):8525-38.
PMID: 25940700
Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats.
Verena Staedtke, Ren-Yuan Bai, Weiyun Sun, Judy Huang, Kathleen Kazuko Kibler, Betty M. Tyler, Gary L. Gallia, Kenneth Kinzler, Bert Vogelstein, Shibin Zhou and Gregory J. Riggins.
Oncotarget. 2015 Mar 20;6(8):5536-46.
PMID: 25849940
Biao Liu, Jeffrey M. Conroy, Carl D. Morrison, Adekunle O. Odunsi, Maochun Qin, Lei Wei, Donald L. Trump, Candace S. Johnson, Song Liu and Jianmin Wang.
Oncotarget. 2015 Mar 20;6(8):5477-89.
PMID: 25849937
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.
Zaidoun Salah, Rand Arafeh, Vadim Maximov, Marco Galasso, Saleh Khawaled, Samah Abou-Sharieha, Stefano Volinia, Kevin B. Jones, Carlo M. Croce, Rami I. Aqeilan.
Oncotarget. 2015 Mar 10;6(7):4920-35.
PMID: 25749032
Rebecca Lamb, Hannah Harrison, Duncan L. Smith, Paul A. Townsend, Thomas Jackson, Bela Ozsvari, Ubaldo E. Martinez-Outschoorn, Richard G. Pestell, Anthony Howell, Michael P. Lisanti, and Federica Sotgia.
Oncotarget. 2015 Mar 10;6(7):4585-601.
PMID: 25671304
Rebecca Lamb, Bela Ozsvari, Camilla L. Lisanti, Herbert B. Tanowitz, Anthony Howell, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, and Michael P. Lisanti.
Oncotarget. 2015 Mar 10;6(7):4569-84.
PMID: 25625193
Alper Yetil, Benedict Anchang, Arvin M. Gouw, Stacey J. Adam, Tahera Zabuawala, Ramya Parameswaran, Jan van Riggelen, Sylvia Plevritis, Dean W. Felsher.
Oncotarget. 2015 Feb 28;6(6):3563-77.
PMID: 25784651
Marco Fiorillo, Andrea F. Verre, Maria Iliut, Maria Peiris-Pagés, Bela Ozsvari, Ricardo Gandara, Anna Rita Cappello, Federica Sotgia, Aravind Vijayaraghavan, and Michael P. Lisanti.
Oncotarget. 2015 Feb 28;6(6):3553-62.
PMID: 25708684
Chad M. McKee, Yunchuan Ding, Jianfeng Zhou, Chunrui Li, Liang Huang, Xiangke Xin, Jing He, Joshua E. Allen, Wafik S. El-Deiry, Yunhong Cao, Ruth J. Muschel, Danmei Xu.
Oncotarget. 2015 Feb 28;6(6):3784-96.
PMID: 25686839
Carlotta Giorgi, Massimo Bonora, Sonia Missiroli, Federica Poletti, Fabian Galindo Ramirez, Giampaolo Morciano, Claudia Morganti, Pier Paolo Pandolfi, Fabio Mammano and Paolo Pinton.
Oncotarget. 2015 Jan 30;6(3):1435-45.
PMID: 25544762
Predicting response to HER2 kinase inhibition.
Jeff Settleman.
Oncotarget. 2015 Jan 20;6(2):588-9.
PMID: 25655645
Frank P. Vendetti, Michael Topper, Peng Huang, Irina Dobromilskaya, Hariharan Easwaran, John Wrangle, Stephen B. Baylin, J. T. Poirier, Charles M. Rudin
Oncotarget. 2015 Jan 1;6(1):56-70.
PMID: 25474141
Ivano Amelio, Alexey A. Antonov, Maria Valeria Catani, Renato Massoud, Francesca Bernassola, Richard A. Knight, Gerry Melino, and Alessandro Rufini.
Oncotarget. 2014 Dec 30;5(24):12820-934.
PMID: 25514460
Jessica Wagner, Christina Leah Kline, Richard S. Pottorf, Bhaskara Rao Nallaganchu, Gary L. Olson, David T. Dicker, Joshua E. Allen, Wafik S. El-Deiry.
Oncotarget. 2014 Dec 30;5(24):12728-37.
PMID: 25587031
MYC regulates the non-coding transcriptome.
Jonathan R. Hart, Thomas C. Roberts, Marc S. Weinberg, Kevin V. Morris, and Peter K. Vogt.
Oncotarget. 2014 Dec 30;5(24):12543-54.
PMID: 25587025
Lisha Xiang, Daniele M. Gilkes, Hongxia Hu, Naoharu Takano, Weibo Luo, Haiquan Lu, John W. Bullen, Debangshu Samanta, Houjie Liang and Gregg L. Semenza.
Oncotarget. 2014 Dec 30;5(24):12509-27.
PMID: 25587023
Classification of current anticancer immunotherapies.
Lorenzo Galluzzi,, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi,, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka FuÄíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou and Guido Kroemer.
Oncotarget. 2014 Dec 30;5(24):12472-508.
PMID: 25537519
Rebecca Lamb, Hannah Harrison, James Hulit, Duncan L. Smith, Michael P. Lisanti, and Federica Sotgia.
Oncotarget. 2014 Nov 30;5(22):11029-37.
PMID: 25415228
Bioinformatics analysis of the serine and glycine pathway in cancer cells.
Alexey Antonov, Massimiliano Agostini, Maria Morello, Marilena Minieri, Gerry Melino, and Ivano Amelio.
Oncotarget. 2014 Nov 30;5(22):11004-13.
PMID: 25436979
Patrizia Vici, Francesca Sperati, Marcello Maugeri-Saccà, Elisa Melucci, Anna Di Benedetto, Luigi Di Lauro, Laura Pizzuti, Domenico Sergi, Irene Terrenato, Luca Esposito, Carmelina Antonella Iannuzzi, Raffaella Pasquale, Claudio Botti, Barbara Fuhrman, Antonio Giordano, Marcella Mottolese, and Maddalena Barba.
Oncotarget. 2014 Nov 15;5(21):10382-92.
PMID: 25071015
Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.
Ying Yan, Ashley L. Hein, Asserewou Etekpo, Katrina M. Burchett, Chi Lin, Charles A. Enke, Surinder K. Batra, Kenneth H. Cowan, Michel M. Ouellette.
Oncotarget. 2014 Nov 15;5(21):10251-70.
PMID: 25344910
Mauro Finicelli, Giovanni Benedetti, Tiziana Squillaro, Barbara Pistilli, Andrea Marcellusi, Paola Mariani, Alfredo Santinelli, Luciano Latini, Umberto Galderisi, Antonio Giordano.
Oncotarget. 2014 Oct 30;5(20):9678-88.
PMID: 25127259
Claudia A. Benavente, David Finkelstein, Dianna A. Johnson, Jean-Christophe Marine, Ruth Ashery-Padan, Michael A. Dyer.
Oncotarget. 2014 Oct 30;5(20):9594-608.
PMID: 25338120
Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells.
Lan Yi, Yvonne Sun, Arnold Levine.
Oncotarget. 2014 Oct 15;5(19):8924-36.
PMID: 25238040
Philipp Raffeiner, Ruth Röck, Andrea Schraffl, Markus Hartl, Jonathan R. Hart, Kim D. Janda, Peter K. Vogt, Eduard Stefan and Klaus Bister.
Oncotarget. 2014 Oct 15;5(19):8869-78.
PMID: 25326649
Hypoxia-inducible factors enhance glutamate signaling in cancer cells.
Hongxia Hu, Naoharu Takano, Lisha Xiang, Daniele M. Gilkes, Weibo Luo, and Gregg L. Semenza.
Oncotarget. 2014 Oct 15;5(19):8853-68.
PMID: 25326682
Oncogene addiction: resetting the safety switch?
Yulin Li, Peter S. Choi, and Dean W. Felsher.
Oncotarget. 2014 Sep 30;5(18):7986-7. No abstract available.
PMID: 25275297
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
Vivien Landré, Barak Rotblat, Sonia Melino, Francesca Bernassola, and Gerry Melino.
Oncotarget. 2014 Sep 30;5(18):7988-8013.
PMID: 25237759
The reverse warburg effect in osteosarcoma
Federica Sotgia, Ubaldo E. Martinez-Outschoorn, and Michael P. Lisanti.
Oncotarget. 2014 Sep 30;5(18):7982-3.
PMID: 25478627
Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer
Rebecca Lamb, Michael P. Lisanti, Robert B. Clarke, and Göran Landberg.
Oncotarget. 2014 Sep 30;5(18):7833-42.
PMID: 25277201
Angelo D’Alessandro, Ivano Amelio, Celia R. Berkers, Alexey Antonov, Karen H. Vousden, Gerry Melino, and Lello Zolla.
Oncotarget. 2014 Sep 30;5(18):7722-33.
PMID: 25229745
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.
Catherine Wilson, Katrina Nicholes, Daisy Bustos, Eva Lin, Qinghua Song, Jean-Philippe Stephan, Donald S. Kirkpatrick and Jeff Settleman.
Oncotarget. 2014 Sep 15;5(17):7328-41.
PMID: 25193862
Matteo Fassan, Luigi Dall’Olmo, Marco Galasso, Chiara Braconi, Marco Pizzi, Stefano Realdon, Stefano Volinia, Nicola Valeri, Pierluigi Gasparini, Raffaele Baffa, Rhonda F. Souza, Caterina Vicentini, Edoardo D’Angelo, Jan Bornschein, Gerard J. Nuovo, Giovanni Zaninotto, Carlo M. Croce and Massimo Rugge.
Oncotarget. 2014 Aug 30;5(16):7162-71.
PMID: 25216530
Luca Ferrari, Anna Pistocchi1, Laura Libera, Nicola Boari, Pietro Mortini, Gianfranco Bellipanni, Antonio Giordano, Franco Cotelli, Paola Riva
Oncotarget. 2014 Jul 30;5(14):5712-24.
PMID: 25071022
Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.
Jie Shen, Qiang Hu, Michael Schrauder, Li Yan, Dan Wang, Leonardo Medico, Yuqing Guo, Song Yao, Qianqian Zhu, Biao Liu, Maochun Qin, Matthias W. Beckmann, Peter A. Fasching, Reiner Strick, Candace S. Johnson, Christine B. Ambrosone, Hua Zhao, Song Liu.
Oncotarget. 2014 Jul 30;5(14):5284-94.
PMID: 25051376
Structural basis of nSH2 regulation and lipid binding in PI3Kα.
Michelle S. Miller, Oleg Schmidt-Kittler, David M. Bolduc, Evan T. Brower, Daniele Chaves-Moreira, Marc Allaire, Kenneth W. Kinzler, Ian G. Jennings, Philip E. Thompson, Philip A. Cole, L. Mario Amzel, Bert Vogelstein and Sandra B. Gabelli.
Oncotarget. 2014 Jul 30;5(14):5198-208.
PMID: 25105564
Immunogenic cell death inducers as anticancer agents.
Oliver Kepp, Laura Senovilla, and Guido Kroemer.
Oncotarget. 2014 Jul 30;5(14):5190-1. No abstract available.
PMID: 25114034
Petra Popovics, Andrew V. Schally, Luca Szalontay, Norman L. Block, and Ferenc G. Rick.
Oncotarget. 2014 Jun 30;5(12):4567-78.
PMID: 24994120
Antoine M. Snijders, Sasha Langley, Jian-Hua Mao, Sandhya Bhatnagar, Kathleen A. Bjornstad, Chris J. Rosen, Alvin Lo, Yurong Huang, Eleanor A. Blakely, Gary H. Karpen, Mina J. Bissell and Andrew J. Wyrobek.
Oncotarget. 2014 Jun 30;5(12):4011-25.
PMID: 24994117
Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma.
Kathleen M. Capaccione, Xuehui Hong, Katherine M. Morgan, Wenyu Liu, J. Michael Bishop, LianXin Liu, Elke Markert, Malik Deen, Christine Minerowicz, Joseph R. Bertino, Thaddeus Allen, and Sharon R. Pine.
Oncotarget. 2014 Jun 15;5(11):3636-50.
PMID: 25004243
Paul K. Wright, Sarah Bowen Jones, Nicholas Ardern, Rebecca Ward, Robert B. Clarke, Federica Sotgia, Michael P. Lisanti, Goran Landberg, and Rebecca Lamb.
Oncotarget. 2014 May 30;5(10):3055-65.
PMID: 24931391
Lavinia Raimondi, Nicola Amodio, Maria Teresa Di Martino, Emanuela Altomare, Marzia Leotta, Daniele Caracciolo, Annamaria Gullà, Antonino Neri, Simona Taverna, Patrizia D’Aquila, Riccardo Alessandro, Antonio Giordano, Pierosandro Tagliaferri and Pierfrancesco Tassone.
Oncotarget. 2014 May 30;5(10):3039-54.
PMID: 24839982
Joshua E. Allen, Bikramajit Singh Saroya, Miriam Kunkel, David T. Dicker, Avisnata Das, Kristi L. Peters, Jamal Joudeh, Junjia Zhu, and Wafik S. El-Deiry.
Oncotarget. 2014 Apr 15;5(7):1753-60.
PMID: 24334302
Ricardo G. Correa, Maryla Krajewska, Carl F. Ware, Motti Gerlic, and John C. Reed.
Oncotarget. 2014 Mar 30;5(6):1666-82.
PMID: 24681825
p63 transcriptionally regulates the expression of matrix metallopeptidase 13.
Ivana Celardo, Alexey Antonov, Ivano Amelio, Margherita Annicchiarico-Petruzzelli, and Gerry Melino.
Oncotarget. 2014 Mar 30;5(6):1279-89.
PMID: 24658133
Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.
Joshua Armenia, Linda Fabris, Francesca Lovat, Stefania Berton, Ilenia Segatto, Sara D’Andrea, Cristina Ivan, Luciano Cascione, George A. Calin, Carlo M. Croce, Alfonso Colombatti, Andrea Vecchione, Barbara Belletti and Gustavo Baldassarre.
Oncotarget. 2014 Mar 15;5(5):1185-97.
PMID: 24727437
Pierluigi Gasparini, Luciano Cascione, Matteo Fassan, Francesca Lovat, Gulnur Guler, Serdar Balci, Cigdem Irkkan, Carl Morrison, Carlo M. Croce, Charles L. Shapiro, Kay Huebner.
Oncotarget. 2014 Mar 15;5(5):1174-84.
PMID: 24632568
Dopamine signaling: target in glioblastoma.
Jiri Bartek, Zdenek Hodny
Oncotarget. 2014 Mar 15;5(5):1116-7. No abstract available.
PMID: 24657925
Francesca Lovat, Hideshi Ishii, Monica Schiappacassi, Matteo Fassan, Mattia Barbareschi, Enzo Galligioni, Pierluigi Gasparini, Gustavo Baldassarre, Carlo M. Croce and Andrea Vecchione.
Oncotarget. 2014 Feb 28;5(4):970-7.
PMID: 24448468
Russell T Burke, Sarah Meadows, Marc M Loriaux, Kevin S. Currie, Scott A. Mitchell, Patricia Maciejewski, Astrid S. Clarke, Julie A. Dipaolo, Brian J. Druker, Brian J. Lannutti ,and Stephen E. Spurgeon.
Oncotarget. 2014 Feb 28;5(4):908-15.
PMID: 24659719
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts.
Xiaoqi Xie, Nitu Bansal, Tazeem Shaik, John E. Kerrigan, Tamara Minko, Olga Garbuzenko,Emine Ercikan Abali, Nadine Johnson-Farley, Debabrata Banerjee, Kathleen W. Scotto and Joseph R Bertino.
Oncotarget. 2014 Feb 28;5(4):901-7.
PMID: 24658650
Role of aberrant PI3K pathway activation in gallbladder tumorigenesis.
Andrea Lunardi, Kaitlyn A. Webster, Antonella Papa, Bhavik Padmani, John G. Clohessy, Roderick T. Bronson and Pier Paolo Pandolfi.
Oncotarget. 2014 Feb 28;5(4):894-900.
PMID: 24658595
Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.
Prashant K. Singh, Leah Preus, Qiang Hu, Li Yan, Mark D. Long, Carl D. Morrison, Mary Nesline, Candace S. Johnson, Shahriar Koochekpour, Manish Kohli, Song Liu, Donald L. Trump, Lara E Sucheston-Campbell, and Moray J. Campbell.
Oncotarget. 2014 Feb 15;5(3):824-40.
PMID: 24583788
Richard Knight, Mikhail Gostev, Sergei Ilisavskii, Anne E Willis, Gerry Melino, and Alexey V Antonov.
Oncotarget. 2014 Feb 15;5(3):659-66.
PMID: 24553133
Huili Li, Katherine B. Chiappinelli, Angela A. Guzzetta, Hariharan Easwaran, Ray-Whay Chiu Yen, Rajita Vatapalli, Michael J. Topper, Jianjun Luo, Roisin M. Connolly, Nilofer S. Azad, Vered Stearns, Drew M. Pardoll, Nancy Davidson, Peter A. Jones, Dennis J. Slamon, Stephen B. Baylin, Cynthia A. Zahnow, Nita Ahuja.
Oncotarget. 2014 Feb 15;5(3):587-98.
PMID: 24583822
RB1 gene inactivation by chromothripsis in human retinoblastoma.
Justina McEvoy, Panduka Nagahawatte, David Finkelstein, Jennifer Richards-Yutz, Marcus Valentine, Jing Ma, Charles Mullighan, Guangchun Song, Xiang Chen, Matthew Wilson, Rachel Brennan, Stanley Pounds, Jared Becksfort, Robert Huether, Charles Lu, Robert S. Fulton, Lucinda L. Fulton, Xin Hong, David J. Dooling, Kerri Ochoa, Elaine R. Mardis, Richard K.Wilson, John Easton, Jinghui Zhang, James R. Downing, Arupa Ganguly, and Michael A. Dyer.
Oncotarget. 2014 Jan 30;5(2):438-50.
PMID: 24509483
Barak Rotblat, Thomas G. P. Grunewald, Gabriel Leprivier, Gerry Melino, and Richard A. Knight.
Oncotarget. 2013 Dec;4(12):2577-90.
PMID: 24342878
He Shen, Carl D. Morrison, Jianmin Zhang, Willie Underwood III, Nuo Yang, Costa Frangou, Kevin Eng, Karen Head, Roni J. Bollag, Sravan K. Kavuri, Amyn M. Rojiani, Yingwei Li, Li Yan, Annette Hill, Anna Woloszynska-Read, Jianmin Wang, Song Liu, Donald L. Trump, and Candace S. Johnson.
Oncotarget. 2013 Nov;4(11):2124-34.
PMID: 24231253
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
John Wrangle, Wei Wang, Alexander Koch, Hariharan Easwaran, Helai P. Mohammad, Xiaoyu Pan,Frank Vendetti, Wim VanCriekinge, Timothy DeMeyer, Zhengzong Du, Princy Parsana, Kristen Rodgers, Ray-Whay Yen, Cynthia A. Zahnow, Janis M. Taube, Julie R. Brahmer, Scott S. Tykodi, Keith Easton, Richard D. Carvajal, Peter A. Jones, Peter W. Laird, Daniel J. Weisenberger, Salina Tsai, Rosalyn A. Juergens, Suzanne L. Topalian, Charles M. Rudin, Malcolm V. Brock, Drew Pardoll, and Stephen B. Baylin.
Oncotarget. 2013 Nov;4(11):2067-79.
PMID: 24162015
NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals.
Sabine Becker-Weimann, Gaofeng Xiong, Saori Furuta, Ju Han, Irene Kuhn, Uri-David Akavia, Dana Pe’er, Mina J Bissell, Ren Xu.
Oncotarget. 2013 Nov;4(11):2010-20.
PMID: 24243820
Marissa V Powers, Melanie Valenti, Susana Miranda, Alison Maloney, Suzanne A. Eccles, George Thomas, Paul A Clarke and Paul Workman.
Oncotarget. 2013 Nov;4(11):1963-75.
PMID: 24185264
Biao Liu, Carl D. Morrison, Candace S. Johnson, Donald L. Trump, Maochun Qin, Jeffrey C. Conroy, Jianmin Wang, and Song Liu.
Oncotarget. 2013 Nov;4(11):1868-81. Review.
PMID: 24240121
Sylvain Couty, Isaac M. Westwood, Andrew Kalusa, Celine Cano, Jon Travers, Kathy Boxall, Chiau Ling Chow, Sam Burns, Jessica Schmitt, Lisa Pickard, Caterina Barillari, P. Craig McAndrew, Paul A. Clarke, Spiros Linardopoulos, Roger J. Griffin, G. Wynne Aherne, Florence I. Raynaud, Paul Workman, Keith Jones, Rob L.M. van Montfort.
Oncotarget. 2013 Oct;4(10):1647-61.
PMID: 24072592
Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, Armida W. M. Fabius,Gilson S. Baia, Charles G. Eberhart, Jon D. Weingart, Gary L. Gallia, Stephen B. Baylin, Timothy A. Chan, and Gregory J. Riggins.
Oncotarget. 2013 Oct;4(10):1737-47.
PMID: 24077805
Andrea Treszl, Zita Steiber, Andrew V. Schally, Norman L Block, Balazs Dezso, Gabor Olah, Bernadett Rozsa, Klara Fodor, Armin Buglyo, Janos Gardi, Andras Berta and Gabor Halmos.
Oncotarget. 2013 Oct;4(10):1721-8.
PMID: 24077773
Lysine-specific modifications of p53: a matter of life and death?
Diana Marouco, Alexander V Garabadgiu, Gerry Melino, and Nick A Barlev.
Oncotarget. 2013 Oct;4(10):1556-71.
PMID: 24298606
Cytokine-induced 'bystander' senescence in DDR and immuno-surveillance.
Zdenek Hodny, Sona Hubackova, Jiri Bartek.
Oncotarget. 2013 Oct;4(10):1552-3. No abstract available.
PMID: 24145286
Wei Luo, Qiang Hu, Dan Wang, Kristin K. Deeb,Yingyu Ma, Carl D. Morrison, Song Liu, Candace S. Johnson and Donald L. Trump.
Oncotarget. 2013 Sep;4(9):1472-83.
PMID: 23978847
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity
Tatiana N Moiseeva, Andrew Bottrill, Gerry Melino, and Nickolai A Barlev.
Oncotarget. 2013 Sep;4(9):1338-48.
PMID: 23907514
Kinase inhibitor therapy in CML: it's what's inside that counts.
Christopher A. Eide, Brian J. Druker, Thomas O’Hare.
Oncotarget. 2013 Sep;4(9):1332-3. No abstract available.
PMID: 23934763
Grazia Saturno, Melanie Valenti, Alexis De Haven Brandon, George V. Thomas, Suzanne Eccles, Paul A. Clarke, and Paul Workman.
Oncotarget. 2013 Aug;4(8):1185-98.
PMID: 23852390
Cancer Metabolism: New Validated Targets for Drug Discovery.
Federica Sotgia, Ubaldo E. Martinez-Outschoorn, and Michael P Lisanti
Oncotarget. 2013 Aug;4(8):1309-16.
PMID: 23896568
Huabo Wang, Jay Chauhan, Angela Hu, Kelsey Pendleton, Jeremy L. Yap, Philip E. Sabato, Jace W. Jones, Mariarita Perri, Jianshi Yu, Erika Cione, Maureen A. Kane, Steven Fletcher, and Edward V. Prochownik,.
Oncotarget. 2013 Jun;4(6):936-47.
PMID: 23801058
Ke Chen, Kongming Wu, Michael Gormley, Adam Ertel, Wei Zhang, Jie Zhou, Gabriele DiSante, Zhiping Li, Hallgeir Rui, Andrew A. Quong, Steven B. McMahon, Haiteng Deng, Michael P. Lisanti, Chenguang Wang, and Richard G. Pestell.
Oncotarget. 2013 Jun;4(6):923-35.
PMID: 23798621
pRb controls estrogen receptor alpha protein stability and activity.
Isabella Caligiuri, Giuseppe Toffoli, Antonio Giordano, and Flavio Rizzolio.
Oncotarget. 2013 Jun;4(6):875-83.
PMID: 23900261
Cross-species genomic and epigenomic landscape of retinoblastoma.
Claudia A. Benavente, Justina D. McEvoy, David Finkelstein, Lei Wei, Guolian Kang, Yong-Dong Wang, Geoffrey Neale, Susan Ragsdale, Virginia Valentine, Armita Bahrami, Jamshid Temirov, Stanley Pounds, Jinghui Zhang, and Michael A. Dyer.
Oncotarget. 2013 Jun;4(6):844-59.
PMID: 23765217
Karoly Szepeshazi, Andrew V. Schally,, Norman L. Block, Gabor Halmos, Mehrdad Nadji, Luca Szalontay, Irving Vidaurre, Andrew Abi-Chaker, Ferenc G. Rick,.
Oncotarget. 2013 May;4(5):751-60.
PMID: 23744510
Arnaldur Hall, Kathrine Damm Meyle, Marina Krarup Lange, Martin Klima, May Sanderhoff, Christina Dahl, Cecilie Abildgaard, Katrine Thorup, Seyed Moein Moghimi, Per Bo Jensen, Jiri Bartek, Per Guldberg and Claus Christensen.
Oncotarget. 2013 Apr;4(4):584-99.
PMID: 23603840
Exomic sequencing of four rare central nervous system tumor types.
Chetan Bettegowda, Nishant Agrawal, Yuchen Jiao, Yuxuan Wang, Laura D. Wood, Fausto J. Rodriguez, Ralph H. Hruban, Gary L. Gallia, Zev A. Binder, Callen J. Riggins, Vafi Salmasi, Gregory J. Riggins, Zachary J. Reitman, Ahmed Rasheed, Stephen Keir, Sueli Shinjo, Suely Marie, Roger McLendon, George Jallo, Bert Vogelstein, Darell Bigner, Hai Yan, Kenneth W. Kinzler and Nickolas Papadopoulos.
Oncotarget. 2013 Apr;4(4):572-83.
PMID: 23592488
Miklos Jaszberenyi, Andrew V. Schally,, Norman L. Block, Mehrdad Nadji, Irving Vidaurre, Luca Szalontay, Ferenc G. Rick.
Oncotarget. 2013 Mar;4(3):422-32.
PMID: 23518876
Vasilisa Aksenova, Lidia Turoverova, Mikhail Khotin, Karl-Eric Magnusson, Eugene Tulchinsky, Gerry Melino, George P Pinaev, Nikolai Barlev, and Dmitri Tentler.
Oncotarget. 2013 Feb;4(2):362-72.
PMID: 23482348
DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells.
M. Zulfiquer Hossain, Megan A. Healey, Calvin Lee, Weijie Poh, Sashidhar R. Yerram, Kalpesh Patel, Nilofer S. Azad, James G. Herman, and Scott E. Kern.
Oncotarget. 2013 Feb;4(2):298-309.
PMID: 23593653
Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression.
Joan C Delto, Takashi Kobayashi, Mitchell C Benson, James McKiernan, and Cory Abate-Shen.
Oncotarget. 2013 Feb;4(2):269-76.
PMID: 23563166
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma.
Maria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, Marta Lionetti, Emanuela Leone, Nicola Amodio, Pietro Hiram Guzzi, Umberto Foresta, Francesco Conforti, Mario Cannataro, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri, and Pierfrancesco Tassone,.
Oncotarget. 2013 Feb;4(2):242-55.
PMID: 23479461
Joshua E. Allen and Wafik S. El-Deiry.
Oncotarget. 2013 Feb;4(2):184-91.
PMID: 23468473
The maintenance of epigenetic states by p53: the guardian of the epigenome.
Arnold J. Levine, Benjamin Greenbaum.
Oncotarget. 2012 Dec;3(12):1503-4. No abstract available.
PMID: 23237909
The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer.
Nicolas Floc'h, and Cory Abate-Shen.
Oncotarget. 2012 Dec;3(12):1483-4.
PMID: 23242005
NRF2 and p53: Januses in cancer?
Barak Rotblat, Gerry Melino, and Richard A. Knight.
Oncotarget. 2012 Nov;3(11):1272-83.
PMID: 23174755
Genetic Induction of the Warburg Effect Inhibits Tumor Growth.
Federica Sotgia, Ubaldo E. Martinez-Outschoorn, Michael P. Lisanti.
Oncotarget. 2012 Nov;3(11):1266-7.
PMID: 23175502
Arnold J. Levine, Chris R. Harris and Anna M. Puzio-Kuter.
Oncotarget. 2012 Nov;3(11):1301-7. No abstract available.
PMID: 23211569
Immunosurveillance against cancer-associated hyperploidy.
Laura Senovilla, Lorenzo Galluzzi, Guillermo Marino, Ilio Vitale, Maria Castedo, Guido Kroemer.
Oncotarget. 2012 Nov;3(11):1270-1. No abstract available.
PMID: 23174699
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
Nicola Amodio, Marzia Leotta, Dina Bellizzi, Maria Teresa Di Martino, Patrizia D’Aquila, Marta Lionetti, Fernanda Fabiani, Emanuela Leone, Anna Maria Gullà, Giuseppe Passarino, Michele Caraglia, Massimo Negrini, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri and Pierfrancesco Tassone.
Oncotarget. 2012 Oct;3(10):1246-58.
PMID: 23100393
Inhibiting the molecular evolution of cancer through HSP90.
Ana Sofia Martins, Faith E. Davies, Paul Workman.
Oncotarget. 2012 Oct;3(10):1054-6. No abstract available.
PMID: 23175477
Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target.
Fang Zhang, Kristi Rothermund, Sajithlal B. Gangadharan, Yves Pommier, Edward V. Prochownik, and John S. Lazo.
Oncotarget. 2012 Sep;3(9):998-1010.
PMID: 22948175
Roberto Perez, Andrew V. Schally,, Irving Vidaurre, Ricardo Rincon, Norman L. Block, Ferenc G. Rick,.
Oncotarget. 2012 Sep;3(9):988-97.
PMID: 22941871
Carmela Guido, Diana Whitaker-Menezes, Zhao Lin, Richard G. Pestell, Anthony Howell, Teresa A. Zimmers, Mathew C. Casimiro, Saveria Aquila, Sebastiano Ando, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, and Michael P. Lisanti.
Oncotarget. 2012 Aug;3(8):798-810.
PMID: 22878233
Shock about heat shock in cancer.
Emmanuel de Billy, Jon Travers, Paul Workman.
Oncotarget. 2012 Aug;3(8):741-3.
PMID: 22964629
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg , Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Jr., Hai Yan
Oncotarget. 2012 Jul;3(7):709-22.
PMID: 22869205
Karoly Szepeshazi , Andrew V. Schally,, Gunhild Keller, Norman L. Block, Daniel Benten, Gabor Halmos, Luca Szalontay, Irving Vidaurre, Miklos Jaszberenyi, Ferenc G. Rick,.
Oncotarget. 2012 Jul;3(7):686-99.
PMID: 22824624
Kalpesh Patel, Sashidhar R. Yerram, Nilofer A. Azad and Scott E. Kern.
Oncotarget. 2012 Jul;3(7):678-85.
PMID: 22824673
Andrew Puca, Giuseppe Russo, Antonio Giordano.
Oncotarget. 2012 Apr;3(4):426-34.
PMID: 22566481
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Rosa Visone, Angelo Veronese, Veronica Balatti, Carlo M. Croce.
Oncotarget. 2012 Feb;3(2):195-202.
PMID: 22350310
Brian A. DeChristopher, Alice C. Fan, Dean W. Felsher, Paul A. Wender.
Oncotarget. 2012 Jan;3(1):58-66.
PMID: 22308267
A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.
Luca D’Agostino and Antonio Giordano.
Oncotarget. 2011 Dec;2(12):1055-74.
PMID: 22170762
Akshal S. Patel, Joshua E. Allen, David T. Dicker, Kristi L. Peters, Jonas M. Sheehan, Michael J. Glantz and Wafik S. El-Deiry.
Oncotarget. 2011 Oct;2(10):752-60.
PMID: 21987585
Weibo Luo and Gregg L. Semenza.
Oncotarget. 2011 Jul;2(7):551-6.
PMID: 21709315
Erik A. Nelson, Sreenath V. Sharma, Jeffrey Settleman, and David A. Frank.
Oncotarget. 2011 Jun;2(6):518-24. Review.
PMID: 21680956
Phosphorylation of AKT: a mutational analysis.
Jonathan R. Hart, Peter K. Vogt.
Oncotarget. 2011 Jun;2(6):467-76.
PMID: 21670491
Mitochondrial compartmentalized protein folding and tumor cell survival.
Dario C. Altieri.
Oncotarget. 2011 Apr;2(4):347-51. Review.
PMID: 21555789
Ryan B. Corcoran, Jeffrey Settleman, Jeffrey A. Engelman.
Oncotarget. 2011 Apr;2(4):336-46. Review.
PMID: 21505228
Paul Workman, Faith E. Davies.
Oncotarget. 2011 Apr;2(4):277-80. No abstract available.
PMID: 21515932
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
Jian He, Jian Wu, Yuchen Jiao, Nina Wagner-Johnston, Richard F. Ambinder, Luis A Diaz, Jr., Kenneth W Kinzler, Bert Vogelstein, and Nickolas Papadopoulos
Oncotarget. 2011 Mar;2(3):178-85.
PMID: 21399237
Francesca Scrimieri, Eric S. Calhoun, Kalpesh Patel, Rigu Gupta,David L. Huso, Ralph H. Hruban, Scott E. Kern.
Oncotarget. 2011 Jan-Feb;2(1-2):69-75.
PMID: 21378412
A robust approach to enhance tumor-selective accumulation of nanoparticles.
Yuan Qiao, Xin Huang, Sridhar Nimmagadda, Renyuan Bai, Verena Staedtke, Catherine A. Foss, Ian Cheong, Matthias Holdhoff, Yoshinori Kato, Martin G. Pomper, Gregory J. Riggins, Kenneth W. Kinzler, Luis A. Diaz, Jr, Bert Vogelstein, Shibin Zhou.
Oncotarget. 2011 Jan-Feb;2(1-2):59-68.
PMID: 21378416
The pursuit of oncotargets through understanding defective cell regulation.
Meng Qiao, Qian Shi, Arthur B. Pardee.
Oncotarget. 2010 Nov;1(7):544-51. Review.
PMID: 21317450
NSP 5a3a: a potential novel cancer target in head and neck carcinoma.
Luca D'agostino, Antonio Giordano.
Oncotarget. 2010 Oct;1(6):423-35.
PMID: 21311098
PI3Kα inhibitors that inhibit metastasis.
Oleg Schmidt-Kittler, Jiuxiang Zhu, Jian Yang, Guosheng Liu, William Hendricks, Christoph Lengauer, Sandra B. Gabelli, Kenneth W. Kinzler, Bert Vogelstein, David L. Huso, Shibin Zhou.
Oncotarget. 2010 Sep;1(5):339-48.
PMID: 21179398
Is miR-29 an oncogene or tumor suppressor in CLL?
Yuri Pekarsky, Carlo M. Croce.
Oncotarget. 2010 Jul;1(3):224-7.
PMID: 20936047
Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.
Mounia Beloueche-Babari, Vaitha Arunan, L. Elizabeth Jackson, Nina Perusinghe, Swee Y. Sharp, Paul Workman, Martin O. Leach.
Oncotarget. 2010 Jul;1(3):185-97.
PMID: 21037799
The war on cancer: have we won the battle but lost the war?
Rachel Brennan, Sara Federico, Michael A. Dyer.
Oncotarget. 2010 Jun;1(2):77-83. No abstract available.
PMID: 20877440
Mikhail Blagosklonny, Andrei Gudkov.
Oncotarget. 2010 May;1(1):2.
PMCID: PMC4053540
Jin Shi, Minghao Sun, Peter K. Vogt.
Oncotarget. 2010 May;1(1):9-21.
PMID: 20634973
Shape-shifting and tumor suppression by PLZF.
Robin M. Hobbs, Pier Paolo Pandolfi.
Oncotarget. 2010 May;1(1):3-5. No abstract available.
PMID: 21293049
Copyright © 2023 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC